- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed/Refractory Systemic Light Chain Amyloidosis
Total 1033 results
-
La Raza Medical CenterCompletedRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaMexico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene Corporation; Biologics...CompletedRelapsed/Refractory Mantle Cell LymphomaUnited States
-
Technische Universität DresdenGerman Cancer Research CenterRecruitingNeoplasms | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Relapsed Diffuse Large B-cell Lymphoma (DLBCL) | Refractory Diffuse Large B-cell Lymphoma (DLBCL)Germany
-
Guangdong Second Provincial General HospitalRecruitingRelapsed or Refractory B-cell LymphomaChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownRelapsed / Refractory Mantle Cell Lymphoma (MCL)China
-
Fujian Medical UniversityUnknown
-
Peking UniversityMarino Biotechnology Co., Ltd.UnknownRelapsed or Refractory B-cell LymphomaChina
-
Marcela V. Maus, M.D.,Ph.D.Kite, A Gilead CompanyActive, not recruitingNon Hodgkin Lymphoma | Neurotoxicity | Neurotoxicity Syndromes | Cytokine Release Syndrome | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaUnited States
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
Shanghai Unicar-Therapy Bio-medicine Technology...RecruitingRelapsed or Refractory Non-Hodgkin's LymphomaChina
-
Institute of Hematology & Blood Diseases Hospital...RecruitingRefractory/Relapsed Autoimmune Hemolytic AnemiaChina
-
Henan Cancer HospitalHenan Hualong Biotechnology CompanyUnknownRefractory | B-Cell Lymphoma Stage I | RelapsedChina
-
Genta IncorporatedCompletedNon-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade LymphomaUnited States
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Cellular Biomedicine Group Ltd.RecruitingRelapsed/Refractory Large B-Cell LymphomaChina
-
Chongqing University Cancer HospitalFundamenta Therapeutics, Ltd.Not yet recruitingRefractory or Relapsed B Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingRelapsed and Refractory B-cell LymphomaChina
-
Eucure (Beijing) Biopharma Co., LtdRecruitingAdvanced Solid Tumors | Relapsed Or Refractory Non-Hodgkin LymphomaChina
-
Kite, A Gilead CompanyHumanigen, Inc.TerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
EVIVE BiotechnologyPeking University Cancer Hospital & InstituteUnknownRelapsed or Refractory B-cell Lymphoma
-
Janssen Biotech, Inc.Pharmacyclics LLC.Approved for marketingRelapsed or Refractory Mantle Cell LymphomaUnited States, Brazil, Puerto Rico
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Institute of Hematology & Blood Diseases Hospital...RecruitingRefractory/Relapsed Autoimmune Hemolytic AnemiaChina
-
Kite, A Gilead CompanyActive, not recruitingRelapsed or Refractory Large B-cell LymphomaUnited States
-
US Oncology ResearchEli Lilly and CompanyCompletedRelapsed or Refractory Mantle Cell Lymphoma (MCL)
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Recurrent CancerUnited States
-
Oncopeptides ABTerminatedRelapsed and/or Relapsed-refractory Multiple MyelomaUnited States, Netherlands, Denmark, Sweden, Italy
-
CARGO TherapeuticsRecruitingCancer | Relapsed/Refractory Large B-cell Lymphoma (LBCL)United States
-
Tarapeutics Science Inc.RecruitingAdvanced Solid Tumor | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryChina
-
Juventas Cell Therapy Ltd.RecruitingRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Stanford UniversityActive, not recruitingLymphoma | Relapsed/Refractory T-cell LymphomasUnited States
-
Cellular Biomedicine Group Ltd.Chinese PLA General HospitalUnknownRelapsed or Refractory Acute Lymphoblastic LeukemiaChina
-
National Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | Relapsed/Refractory | B CellUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
Aibin Liang,MD,Ph.D.CARsgen Therapeutics Co., Ltd.RecruitingRelapsed and/or Refractory Multiple Myeloma | Plasma Cell Leukemia in RelapseChina
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaSpain
-
BeiGeneRecruitingMantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma (MCL)United States, China, Israel, Belgium, Poland, Spain, Turkey, Brazil, Italy, Canada, United Kingdom, France, Germany, Argentina, Puerto Rico
-
Chongqing Precision Biotech Co., LtdRecruitingNon Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaChina
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Aggressive B-Cell LymphomaUnited States, Germany, Spain
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
AHS Cancer Control AlbertaTom Baker Cancer CentreTerminatedFollicular Lymphoma | Hodgkin's Lymphoma - Relapsed/Refractory | Non-Hodgkin's Lymphoma - AggressiveCanada
-
BeiGeneCompletedRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaChina
-
Menarini GroupTerminatedMetastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin LymphomaItaly, Spain, Belgium, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.TerminatedRelapsed or Refractory Primary Mediastinal B-cell Lymphoma (rrPMBCL)China
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Myelofibrosis | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Lymphoid Malignancies | Relapsed Non-Hodgkin Lymphoma and other conditionsUnited States
-
Hospital Israelita Albert EinsteinMiltenyi Biotec, Inc.Not yet recruitingAcute Lymphoblastic Leukemia, in Relapse | B-cell Lymphoma Refractory | B-cell Lymphoma Recurrent | Chronic Lymphocytic Leukemia Recurrent | Chronic Lymphocytic Leukemia Refractory | Acute Lymphoblastic Leukemia RefractoryBrazil
-
ImmPACT BioRecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSRecruitingRefractory Mantle Cell Lymphoma | Relapsed Mantle Cell LymphomaItaly